Dr Reddy’s completes Phase I study of DRL_TC, a tocilizumab biosimilar candidate EP News Bureau Jun 5, 2023 This Phase I study used an intravenous (IV) formulation to evaluate the pharmacokinetic equivalence, safety and immunogenicity of…
